Titre : | Addiction, Vol.112, n°2 - February 2017 |
Type de document : | Bulletin : Périodique |
Paru le : | 01/02/2017 |
Année de publication : | 2017 |
Format : | 197-380 |
Langues: | Anglais |
Note de contenu : |
CONTENTS:
- Yes, people can die from opiate withdrawal [Editorial]. Darke S., Larney S., Farrell M., p. 199-200. - Hepatitis C virus prevention and treatment prioritization - ethical, economic and evidential dimensions of early rather than delayed treatment for people who inject drugs [Editorial]. Hickman M., Martin N.K., Huxtable R., p. 201-203. - Addiction Debates: challenging ideas, challenging ourselves. Neale J., Humphreys K., p. 204-204. - Introduction to Horizons Review series on neuroimaging. Lingford-Hughes A., p. 205-206. - Selection biases in observational studies affect associations between 'moderate' alcohol consumption and mortality [Addiction debate]. Naimi T.S., Stockwell T., Zhao J., Xuan Z., Dangardt F., Saitz R., et al., p. 207-214. - Beneficial effects of moderate alcohol use - a case for Occam's razor? Gmel G., p. 215-217. - On bias in alcohol epidemiology and the search for the perfect study. Roerecke M., p. 217-218. - The protective effects of moderate drinking: lies, damned lies, and... selection biases? Britton A., Bell S., p. 218-219. - Selection bias and relationships between alcohol consumption and mortality. Naimi T.S., Stockwell T., Saitz R., Chikritzhs T., p. 220-221. - Alcohol consumption as a cause of cancer [Addiction debate]. Connor J., p. 222-228. - Why is alcohol cancer's best-kept secret? Slevin T., Chikritzhs T., p. 229-230. - Alcohol's contribution to cancer is underestimated for exactly the same reason that its contribution to cardioprotection is overestimated. Stockwell T., Zhao J., p. 230-232. - Alcohol and cancer - individual risk factors. Seitz H.K., p. 232-233. - Strong epidemiological evidence that alcohol causes cancer, but how might the public interpret this information? Emslie C., Macdonald S., p. 233-235. - Effectiveness of pharmacy-based needle/syringe exchange programme for people who inject drugs: a systematic review and meta-analysis. Sawangjit R., Khan T.M., Chaiyakunapruk N., p. 236-247. - Commentary on Sawangjit et al. (2017): There is still much to be determined before policy makers can choose pharmacy needle and syringe programmes (NSP) confidently over other models of NSP provision. Scott J., p. 248-249. - The role of birth cohorts in long-term trends in liver cirrhosis mortality across eight European countries. Trias-Llimos S., Bijlsma M.J., Janssen F., p. 250-258. - Commentary on Trias-Llimos et al. (2017): Birth cohort research - an essential tool to guide public health interventions. Lazarus J.V., Bromberg D.J., p. 259-260. - The effect of liquor licensing restrictions on assault: a quasi-experimental study in Sydney, Australia. Menéndez P., Kypri K., Weatherburn D., p. 261-268. - A momentary exposures analysis of proximity to alcohol outlets and risk for assault. Morrison C.N., Dong B., Branas C.C., Richmond T.S., Wiebe D.J., p. 269-278. - Trajectories of cannabis use disorder: risk factors, clinical characteristics and outcomes. Kosty D.B., Seeley J.R., Farmer R.F., Stevens J.J., Lewinsohn P.M., p. 279-287. - Commentary on Kosty et al. (2017): Understanding risk classes for cannabis use disorder requires knowledge of exposure, environment and genetic effects. Hines L.A., p. 288-289. - What happened to the HIV epidemic among non-injecting drug users in New York City? Des Jarlais D.C., Arasteh K., McKnight C., Feelemyer J., Campbell A.N.C., Tross S., et al., p. 290-298. - Commentary on Des Jarlais et al. (2017): Robust public health policies as a way forward in the HIV epidemic. Whitehead N.E., p. 299-300. - Evaluating the impact of a national naloxone programme on ambulance attendance at overdose incidents: a controlled time-series analysis. McAuley A., Bouttell J., Barnsdale L., Mackay D., Lewsey J., Hunter C., et al., p. 301-308. - Commentary on McAuley et al. (2017): Naloxone programs must reduce marginalization and improve access to comprehensive emergency care. M. Orkin A., Buchman D.Z., p. 309-310. - Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP). Lin D.H., Lucas E., Murimi I.B., Jackson K., Baier M., Frattaroli S., et al., p. 311-319. - Impact of laws restricting the sale of tobacco to minors on adolescent smoking and perceived obtainability of cigarettes: an intervention-control pre-post study of 19 European Union countries. Kuipers M.A.G., Brandhof S.D., Monshouwer K., Stronks K., Kunst A.E., p. 320-329. - What a difference a day makes: differences in initial abstinence response during a smoking cessation attempt. Piper M.E., Vasilenko S.A., Cook J.W., Lanza S.T., p. 330-339. - Do never smokers make up an increasing share of snus users as cigarette smoking declines? Changes in smoking status among male snus users in Norway 2003-15. Lund K.E., Vedøy T.F., Bauld L., p. 340-348. - Impact of smoking reduced nicotine content cigarettes on sensitivity to cigarette price: further results from a multi-site clinical trial. Smith T.T., Cassidy R.N., Tidey J.W., Luo X., Le C.T., Hatsukami D.K., et al., p. 349-359. - The neurobiology of addiction: the perspective from magnetic resonance imaging present and future. Suckling J., Nestor L.J., p. 360-369. - We need a media platform perspective on alcohol marketing: a reply to Lobstein et al. Carah N., Meurk C., p. 370-370. - Use of digital media for alcohol marketing: Response to Carah & Meurk. Lobstein T., Landon J., Thornton N., Jernigan D., p. 371-372. - The benefits of using the UPPS model of impulsivity rather than the Big Five when assessing the relationship between personality and problem gambling. Canale N., Vieno A., Bowden-Jones H., Billieux J., p. 372-373. |
Cote : | Abonnement |
Lien : | http://onlinelibrary.wiley.com/doi/10.1111/add.v112.2/issuetoc |
Dépouillements
Ajouter le résultat dans votre panierArticle : Périodique
Aims: To appraise the evidence critically for effectiveness of pharmacy-based needle/syringe exchange programmes (pharmacy-based NSPs) on risk behaviours (RBs), HIV/HCV prevalence and economic outcomes among people who inject drugs (PWID). Desig[...]
Nouveauté
Article : Périodique
Aims: To estimate cannabis use disorder (CUD) trajectory classes from ages 14 to 30 years and compare classes on clinical characteristics, risk factors and psychosocial outcomes.
Design: Four waves (T1-T4) of data from an epidemiological study[...]
Nouveauté
Article : Périodique
D. C. DES JARLAIS ;
K. ARASTEH ;
C. McKNIGHT ;
J. FEELEMYER ;
A. N. C. CAMPBELL ;
S. TROSS ;
H. L. F. COOPER ;
H. HAGAN ;
D. C. PERLMAN
|
Background and aims: HIV has reached high prevalence in many non-injecting drug user (NIDU) populations. The aims of this study were to (1) examine the trend in HIV prevalence among non-injecting cocaine and heroin NIDUs in New York City, (2) id[...]
Nouveauté
Article : Périodique
Aims: To estimate the impact of introducing sales restriction laws in Europe by measuring changes in adolescent smoking prevalence and perceived obtainability of cigarettes over time in countries that have recently introduced sales restriction l[...]
Nouveauté
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil